Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Medline Unite announced today that it received FDA 510(k) clearance for its Reflex Hybrid nitinol implant system.

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is joining the fight.

Sometimes, they just put it off, said Dr. Antoine Pham, an internal medicine doctor with Thrive Medical. He has started prescribing a new kind of screening — the Shield blood test — for his patients ...

Also Read: FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients The approval is based on results from the DESTINY-Breast06 Phase 3 trial.

A federal judge has thrown out Amgen’s lawsuit against the state board empowered to set price ceilings on prescription drugs deemed unaffordable in Colorado, finding that the maker of arthritis ...

The board of Indian stock exchange BSE limited approved a 2:1 bonus share issue, as per the filing on Sunday. As per the announcement, the BSE will grant two shares for every one held by ...